Q&A: When was America greatest? And is it safe for LGBT+ people to visit the US?
In this week's Talking Politics USA, the team answer your questions including when was America greatest? And if you could meet one US president who would it be?
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Elon Musk reveals shocking results from drug use test
Elon Musk reveals shocking results from drug use test originally appeared on TheStreet. Elon Musk, the world's wealthiest person and President Donald Trump's onetime ally, has finally responded to allegations of drug abuse. On June 17, Musk shared a drug test report on X that shows negative for substances such as ketamine, cocaine, amphetamines, ecstasy, etc. Musk, who used to share his enthusiasm for cryptocurrencies quite often, has cultivated a sizeable fan base among the crypto community. Crypto Twitter was quick to respond to the billionaire's latest post, being curious and humorous. An advisor at the OKX crypto exchange, @Jeremyybtc, asked Grok to explain the details of Musk's post. The AI chatbot said the billionaire's drug results are negative but cautioned that it's "a snapshot, not current proof." In response to Musk's now-viral post, popular crypto YouTuber @TheDustyBC exclaimed: That's the fastest?!?!?!? Another popular Crypto Twitter account, @TheMisterFrog, didn't beat around the bush and straightaway asked Musk to "pump (sic) those numbers up haha." A prominent account, @DogecoinNorway, that claims to like Dogecoin, crypto, and Tesla (Nasdaq: TSLA) and is followed by Musk himself, posted a meme that referenced the viral moment from the Joe Rogan podcast in September 2018 when Musk appeared to be allegedly smoking marijuana. On May 30, the New York Times published a report in which it alleged Musk consumed ketamine, ecstasy, etc., which raised eyebrows during his stint at the Department of Government Efficiency (DOGE). Following his exit from the department, Musk had a nasty feud with President Donald Trump over the "big, beautiful bill." When Musk alleged Trump was named in the "Epstein files," some accounts on Crypto Twitter went ballistic. @CantEverDie challenged Musk directly: 'If you knew this why did you willingly work with a pedophile?' Though Musk later apologized for his X posts, the relationship between the two figures now is hardly as friendly as before. Elon Musk reveals shocking results from drug use test first appeared on TheStreet on Jun 17, 2025 This story was originally reported by TheStreet on Jun 17, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 minutes ago
- Yahoo
Bayern Munich set Club World Cup record with 10-0 thrashing of Auckland City
Bayern Munich put 10 goals past part-time Auckland City FC to record the biggest ever Club World Cup victory, including from the previous format. The German giants were 6-0 up by half time, before Jamal Musiala came off the bench to score a second-half hat-trick and the departing Thomas Muller took Bayern to double figures late on. Advertisement The Group B fixture was expected to be a huge mismatch, given the enormous gulf between the teams, with amateurs Auckland City the only non-professional side to be taking part in the inaugural 32-team Club World Cup. Watch every Fifa Club World Cup game free on DAZN. Sign up here now . Jamal Musiala scored a second-half hat-trick (Getty Images) While Auckland City have won the last four Oceania Champions League titles, and 11 of the last 13, the New Zealand club do not employ their players full time and many have had to take annual leave to travel to the United States. And while Auckland City have qualified for several other Club World Cup tournaments, their journey has usually come to an end in the first-round of the old format, and before playing either champions of Europe and South America. Advertisement But the new group stage means Auckland City are guaranteed to play three matches and, after their thrashing at the hands of Bayern Munich, they will also face Benfica and Boca Juniors before travelling back to New Zealand. New Zealand does not have a professional men's football league, with the top two teams in the country - Wellington Phoenix and Auckland FC - playing their matches in Australia's A-League. But because Australia play in the Asian Football Confederation, both Wellington Phoenix and Auckland FC are ineligible to play in the Oceania Champions League, leaving Auckland City FC to dominate. The Navy Blues defeated Hekari United, of Papua New Guinea, to win their latest OFC Champions League title and qualify for the newly expanded Club World Cup tournament. Advertisement Staff from Auckland City also revealed that flying the squad out to the United States will cost the club more money than it makes in a year - but they will be rewarded by Club World Cup prize money. By contrast, five-time European champions Bayern Munich fielded a strong starting line-up that included Harry Kane and Michael Olise. The value Bayern's squad in transfer fees was estimated at £770m, around 700 times that of Auckland City's squad value of just over £1.2m. With that in mind, Auckland must have been fearing the worst when they trailed 6-0 at half time, but could not keep the scoreline to single-figures after Musiala resumed the scoring. The victory surpassed Al Hilal's 6-1 win over Al Jazira in 2021. You can sign up to DAZN to watch every Club World Cup game for free
Yahoo
4 minutes ago
- Yahoo
HKSTP Teams Up with HKU and CUHK Medical Schools to Showcase Hong Kong's Life & Health Innovations at BIO International Convention
Hong Kong SAR--(Newsfile Corp. - June 17, 2025) - Hong Kong Science and Technology Parks Corporation (HKSTP), in collaboration with InvestHK, led 16 prominent life and health technology companies to BIO 2025, the world's largest biotechnology event, held in Boston, USA, from June 16 to 19. This year marks the first time HKSTP joined forces with Hong Kong's two leading medical faculties--the LKS Faculty of Medicine at The University of Hong Kong (HKU) and the Faculty of Medicine at The Chinese University of Hong Kong (CUHK) - to form a delegation, showcasing Hong Kong's cutting-edge research capabilities and innovation potential in life sciences and health technologies. The initiative further strengthens Hong Kong's position as a world-class biotech innovation hub. In collaboration with InvestHK, HKSTP joined forces with the LKS Faculty of Medicine at The University of Hong Kong (HKU) and the Faculty of Medicine at The Chinese University of Hong Kong (CUHK) for the first time to form a delegation and led 16 prominent life and health technology companies to showcase at BIO 2025 held in Boston, USA. To view an enhanced version of this graphic, please visit: The HKSTP Pavilion highlighted the groundbreaking technologies and products of its park companies, featuring innovative solutions across diverse fields such as novel drug development, diagnostic technologies, and medical innovation. Among the 16 participating companies, they were the members of HKSTP's incubation programmes including Incu-Bio and ELITE Programme, cutting-edge work from the InnoHK research centers, and other outstanding biotech companies. On the first day of the exhibition, the delegation successfully attracted attention from global industry leaders, corporate partners, and venture capital firms. During BIO 2025, HKSTP and its park companies made significant strides in fostering cross-border innovation ecosystems and exploring new market opportunities: Immuno Cure, partnering with HKUMed, the developer of the first-in-human novel therapeutic HIV vaccine ICVAX, announced its collaboration with PharmaJet to explore the application of a needle-free vaccination solution, accelerating the global commercialization pathway for ICVAX. HKSTP signed a partnership agreement with DLRC to provide legal advisory services in clinical trials and certification, promoting global ecosystem collaboration and growth. Mr. Albert Wong, CEO of HKSTP, said: "We are thrilled to partner with two leading medical schools for the first time at BIO 2025, demonstrating Hong Kong's breakthroughs and innovation in life and health technology. This delegation not only deepens collaboration between Hong Kong and top global research institutions but also highlights our unique advantages as a core I&T hub in the Greater Bay Area. With strong policy and funding support from the HKSAR government, Hong Kong will further serve as a bridge connecting Mainland China and global tech partnerships, solidifying its leadership in life sciences innovation." Ahead of BIO 2025, the delegation participated in the "2025 Biomedical Pitch Competition", co-organized by the Boston Capital Investment Club (BCIC) and HKSTP. The event connects global life and health innovators with investors and business partners. Three HKSTP companies--ARBELE, GenEditBio, and Cogsmart--excelled in the preliminary rounds, competing against over 100 global life sciences firms, with ARBELE, HKUMed's affiliated spin-off company, winning the championship, underscoring Hong Kong's research excellence. Over the past three years, this platform has helped startups secure over USD 100 million in funding and connect with hundreds of international investors and partners, driving further business growth. HKSTP is committed to propelling Hong Kong's life sciences sector onto the global stage, showcasing the city's unique strengths to attract international enterprises and talent. The delegation also organized networking events and visits, enabling Hong Kong companies to engage with overseas investors, leading corporations, and renowned academic institutions, including visits to MIT Professor Robert Langer (Described as "Edison of Medicine"), Harvard Innovation Labs, Cambridge Innovation Center, and more. This initiative reinforces Hong Kong's sustainable development in life sciences and its role as a global innovation leader. Appendix: List of Park Companies Participating in BIO 2025: Allegrow Biotech Limited ARBELE Limited Beth Bioinformatics Co., Limited Centre for Translational Stem Cell Biology The Centre for Virology, Vaccinology, and Therapeutics DECODE CURE Limited GenEditBio Limited Great Bay Bio Hong Kong Universal Biologicals Company Limited Immuno Cure Holding (HK) Limited The Institute for Innovation, Translation and Policy Research (ITPR) LEE'S PHARMACEUTICAL (HK) LIMITED Serilink Biotechnology Company Limited Xiaomo Biotech Limited XUXIN (HongKong) Biotechnology Co., Limited Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited Hashtag: #HKSTP The issuer is solely responsible for the content of this announcement. About Hong Kong Science and Technology Parks Corporation Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 to create a thriving I&T ecosystem grooming 13 unicorns, more than 15,000 research professionals and over 2,300 technology companies from 25 countries and regions focused on developing healthtech, AI and robotics, fintech and smart city technologies, etc. Our growing innovation ecosystem offers comprehensive support to attract and nurture talent, accelerate and commercialise innovation for technology ventures, with the I&T journey built around our key locations of Hong Kong Science Park in Pak Shek Kok, InnoCentre in Kowloon Tong and three modern InnoParks in Tai Po, Tseung Kwan O and Yuen Long realising a vision of new industrialisation for Hong Kong, where sectors including advanced manufacturing, micro-electronics and biotechnology are being reimagined. Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen plays positive roles in connecting the world and the mainland with our proximity, strengthening cross-border exchange to bring advantages in attracting global talent and allowing possibilities for the development of technology companies in seven key areas: Medtech, big data and AI, robotics, new materials, microelectronics, fintech and sustainability, with both dry and wet laboratories, co-working space, conference and exhibition facilities, and more. Through our R&D infrastructure, startup support and enterprise services, commercialisation and investment expertise, partnership networks and talent traction, HKSTP continues to contribute in stablishing I&T as a pillar of growth for Hong Kong. More information about HKSTP is available at Media Contact: Angela LauPhone: +852 2629 6633Email: To view the source version of this press release, please visit Sign in to access your portfolio
